The disease-specific pathway of multiple sclerosis (MS) signaling was upregulated across all YWH groups, marked by shared upregulation of interferon-responsive genes such as PARP9 and PARP14, indicating persistent immune activation despite viral suppression [94]. Here, PARP9 is linked to myeloid sarcoma.